Researchers from the UEA in Norwich have developed a new urine test for prostate cancer which also shows how aggressive the disease is.
- Credit: PA
Researchers from the University of East Anglia have developed a new urine test for prostate cancer that could reduce the need for invasive biopsies.
A new study published today shows how an experimental new test called ‘ExoGrail’ has the potential to revolutionise how patients with suspected prostate cancer are risk-assessed prior to a biopsy.
Prostate cancer is the most common cancer in men in the UK. It usually develops slowly and the majority of cancers will not require treatment in a man’s lifetime.